• 1
    De Petrocellis L & Di Marzo V (2009) An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab 23, 115.
  • 2
    Rozenfeld R & Devi LA (2008) Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 22, 23112322.
  • 3
    den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, Kruse CG, Maccarrone M, Wadman WJ & Werkman TR (2012) Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci USA 109, 35343539.
  • 4
    Zygmunt PM, Petersson J, Andersson DA, Chuang H-H, Sørgård M, Di Marzo V, Julius D & Högestätt E (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452457.
  • 5
    Wilson RI & Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296, 678682.
  • 6
    Deutsch DG & Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46, 791796.
  • 7
    Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C & Plomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686691.
  • 8
    Bojesen IN & Hansen HS (2003) Binding of anandamide to bovine serum albumin. J Lipid Res 44, 17901794.
  • 9
    Hillard CJ, Edgemond WS, Jarrahian A & Campbell WB (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69, 631638.
  • 10
    Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie X-Q & Makriyannis A (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci USA 96, 58025807.
  • 11
    Jacobsson SO & Fowler CJ (2001) Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br J Pharmacol 132, 17431754.
  • 12
    Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A & Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 10941097.
  • 13
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG & Di Marzo V (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483, 5256.
  • 14
    López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J & Ramos JA (2003) Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J Med Chem 46, 15121522.
  • 15
    Ortar G, Ligresti A, De Petrocellis L, Morera E & Di Marzo V (2003) Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65, 14731481.
  • 16
    Ronesi J, Gerdeman GL & Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24, 16731679.
  • 17
    Chicca A, Marazzi J, Nicolussi S & Gertsch J (2012) Evidence for bidirectional endocannabinoid transport across cell membranes. J Biol Chem 287, 3466034682.
  • 18
    Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF et al. (2012) Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 73, 360373.
  • 19
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel S, Makriyannis A & Goldberg S (2007) The endogenous cannabinoid anandamide produces ∂-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. J Pharmacol Exp Ther 321, 370380.
  • 20
    Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7, 438455.
  • 21
    Jarrahian A, Manna S, Edgemond WS, Campbell WB & Hillard CJ (2000) Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter. J Neurochem 74, 25972606.
  • 22
    Rang HP, Dale MM, Ritter JM, Flower RJ & Henderson G (2012) Rang & Dale's Pharmacology, 7th edn, pp. 221227. Elsevier Churchill Livingstone, Edinburgh.
  • 23
    Bojesen IN & Hansen HS (2005) Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 46, 16521659.
  • 24
    Kaczocha M, Hermann A, Glaser ST, Bojesen IN & Deutsch DG (2006) Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J Biol Chem 281, 90669075.
  • 25
    Ligresti A, Morera E, van der Stelt M, Monory K, Lutz B, Ortar G & Di Marzo V (2004) Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem J 380, 265272.
  • 26
    Glaser ST, Abumrad NA, Fatade F, Studholme MK & Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100, 42694274.
  • 27
    Sandberg A & Fowler CJ (2005) Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. Chem Phys Lipids 134, 131139.
  • 28
    Thors L & Fowler CJ (2006) Is there a temperature-dependent uptake of anandamide into cells? Br J Pharmacol 149, 7381.
  • 29
    Fasia L, Karava V & Siafaka-Kapadai A (2003) Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? Eur J Biochem 270, 34983506.
  • 30
    Rimmerman N, Hughes H, Bradshaw H, Pazos M, Mackie K, Prieto A & Walker J (2008) Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br J Pharmacol 153, 380389.
  • 31
    Rimmerman N, Bradshaw HB, Kozela E, Levy R, Juknat A & Vogel Z (2012) Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1. Br J Pharmacol 165, 24362449.
  • 32
    Ramakrishnan M, Kenoth R, Kamlekar RK, Chandra MS, Radhakrishnan TP & Swamy MJ (2002) N-Myristoylethanolamine-cholesterol (1:1) complex: first evidence from differential scanning calorimetry, fast-atom-bombardment mass spectrometry and computational modelling. FEBS Lett 531, 343347.
  • 33
    Bari M, Paradisi A, Pasquariello N & Maccarrone M (2005) Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. J Neurosci Res 81, 275283.
  • 34
    Bari M, Battista N, Fezza F, Finazzi-Agrò A & Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280, 1221212220.
  • 35
    Ligresti A, De Petrocellis L, Hernán Pérez de la Ossa D, Aberturas R, Cristino L, Moriello AS, Finizio A, Gil ME, Torres A-I et al. (2010) Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter. PLoS One 5, e10239.
  • 36
    Thors L & Fowler CJ (2007) The effect of methyl-β-cyclodextrin treatment upon the viability and anandamide uptake capability of C6 glioma and P19 embryonic carcinoma cells.
  • 37
    Di Pasquale E, Chahinian H, Sanchez P & Fantini J (2009) The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent. PLoS One 4, e4989.
  • 38
    Kaczocha M, Lin Q, Nelson LD, McKinney MK, Cravatt BF, London E & Deutsch DG (2012) Anandamide externally added to lipid vesicles containing-trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion. ACS Chem Neurosci 3, 364368.
  • 39
    Hillard C & Jarrahian A (2000) The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 108, 123134.
  • 40
    Rakhshan F, Day TA, Blakeley RD & Barker EL (2000) Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292, 960967.
  • 41
    Oddi S, Fezza F, Pasquariello N, De Simone C, Rapino C, Dainese E, Finazzi-Agrò A & Maccarrone M (2008) Evidence for the intracellular accumulation of anandamide in adiposomes. Cell Mol Life Sci 65, 840850.
  • 42
    Kaczocha M, Glaser ST, Chae J, Brown DA & Deutsch DG (2010) Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. J Biol Chem 285, 27962806.
  • 43
    Thors L, Eriksson J & Fowler CJ (2007) Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol 152, 744750.
  • 44
    Fowler CJ & Ghafouri N (2008) Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? Pharmacol Res 58, 7276.
  • 45
    Ortega-Gutiérrez S, Hawkins EG, Viso A, López-Rodríguez ML & Cravatt BF (2004) Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry 43, 81848190.
  • 46
    Fegley D, Kathuria S, Mercier R, Li C-M, Goutopoulos A, Makriyannis A & Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101, 87568761.
  • 47
    Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, Armirotti A, Garau G et al. (2011) A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 15, 6469.
  • 48
    Kaczocha M, Glaser ST & Deutsch DG (2009) Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 106, 63756380.
  • 49
    Oddi S, Fezza F, Pasquariello N, D'Agostino A, Catanzaro G, De Simone C, Rapino C, Finazzi-Agrò A & Maccarrone M (2009) Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem Biol 16, 624632.
  • 50
    Kaczocha M, Vivieca S, Sun J, Glaser ST & Deutsch DG (2012) Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem 287, 34153424.
  • 51
    Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I & Deutsch DG (2012) Targeting fatty acid binding protein (FABP) anandamide transporters – a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. PLoS One 7, e50968.
  • 52
    La Rana G, Russo G, Campolongo P, Bortolato M, Mangieri R, Cuomo V, Iacono A, Mattace Raso G, Meli R, Piomelli D et al. (2006) Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. J Pharmacol Exp Ther 317, 13651371.
  • 53
    Björklund E, Blomqvist AE, Piomelli D, Bottegoni G & Fowler CJ (2012) Functional measurement of FLAT-sensitive anandamide uptake into three rat cell lines. 22th Annual Symposium on the Cannabinoids, Burlington, VT, International Cannabinoid Research Society, abstract P1–16.
  • 54
    Leung KN, Vivieca S, Sun J, Glaser ST, Deutsch DG & Kaczocha M (2012) FLAT is not an intracellular anandamide transporter. 22th Annual Symposium on the Cannabinoids, Burlington, VT, International Cannabinoid Research Society, abstract 59.
  • 55
    Guzmán M, Lo Verme J, Fu J, Oveisi F, Blázquez C & Piomelli D (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α). J Biol Chem 279, 2784927854.
  • 56
    Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA & Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264, 258267.
  • 57
    Beltramo M & Piomelli D (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. NeuroReport 11, 12311235.
  • 58
    McFarland MJ, Porter AC, Rakhshan FR, Rawat DS, Gibbs RA & Barker EL (2004) A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J Biol Chem 279, 4199141997.
  • 59
    McFarland MJ, Bardell TK, Yates ML, Placzek EA & Barker EL (2008) RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. Mol Pharmacol 74, 101108.
  • 60
    Thors L, Alajakku K & Fowler CJ (2007) The ‘specific’ tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. Br J Pharmacol 150, 951960.
  • 61
    Hillard C & Jarrahian A (2005) Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology 48, 10721078.
  • 62
    Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W & Cravatt BF (2010) Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 4961.
  • 63
    Waleh NS, Cravatt BF, Apte-Deshpande A, Terao A & Kilduff TS (2002) Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene 291, 203210.
  • 64
    Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agrò A & Rossi A (2003) Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278, 3272632732.
  • 65
    Maccarrone M, Di Rienzo M, Finazzi-Agrò A & Rossi A (2003) Leptin activates the anandamide hydrolase promoter in hyman T lymphocytes through STAT3. J Biol Chem 278, 1331813324.
  • 66
    Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C & Finazzi-Agrò A (2001) Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 166, 71837189.
  • 67
    Maccarrone M, Bari M, Battista N & Finazzi-Agrò A (2002) Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 100, 40404048.
  • 68
    Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, Di Marzo V & Finazzi-Agrò A (2001) Lipopolysaccharide downregulates fatty acid amide hydrolase levels in human peripheral lymphocytes. Arch Biochem Biophys 393, 321328.
  • 69
    Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V & Finazzi-Agrò A (2000) Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem 275, 1348413492.
  • 70
    Thors L & Fowler CJ (2009) Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids. Eur J Pharmacol 621, 1018.